OC-0280 ReRT with bevacizumab is related to lower rate of radionecrosis as reRT alone for recurrent glioma. (April 2019) - Fleischmann, D.; Jenn, J.; Corradini, S.; Ruf, V.; Forbrig, R.; Unterrainer, M.; Thon, N.; Kreth, F.W.; Belka, C.; Niyazi, M.